@research: Would it be possible to find out whether Dr. Schneider will perform a clinical phase III trial with extravenous GM1 ?
Hi Mister X
From Dr Schneider's email it sounds as though the results of his recent Phase IIa study were promising so I'm sure that he will be keen to move forward with larger, longer trials.
If you'd like to ask Dr Schneider more about his plans for GM1 you can contact him through his university (that's what I did!).
Hope that's helpful!
Best wishes
Claire
(Research team)
From Dr Schneider's email it sounds as though the results of his recent Phase IIa study were promising so I'm sure that he will be keen to move forward with larger, longer trials.
If you'd like to ask Dr Schneider more about his plans for GM1 you can contact him through his university (that's what I did!).
Hope that's helpful!
Best wishes
Claire
(Research team)
Thanks for the suggestion. But I don't think it is necessary to contact him about it. I think I found the answer on my question already:
http://apexutf.shellprompt.net/pls/apex/f?p=162:12:278198596352437:::::
A big black number 4 on the clinical phase II trial of GM1 ganglioside. Seems like there will be no phase III.
http://apexutf.shellprompt.net/pls/apex/f?p=162:12:278198596352437:::::
A big black number 4 on the clinical phase II trial of GM1 ganglioside. Seems like there will be no phase III.